Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126733742 | 12673374 | 2 | F | 20160720 | 20160908 | 20160822 | 20160919 | EXP | FR-SA-2016SA149374 | AVENTIS | 40.00 | YR | A | F | Y | 0.00000 | 20160919 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126733742 | 12673374 | 1 | SS | PIRILENE | PYRAZINAMIDE | 1 | Oral | Y | U | 0 | 2 | G | QD | ||||||
| 126733742 | 12673374 | 2 | PS | RIFADINE | RIFAMPIN | 1 | Oral | U | 50420 | 600 | MG | QD | |||||||
| 126733742 | 12673374 | 3 | SS | PARACETAMOL | ACETAMINOPHEN | 1 | Oral | DOSE AND DAILY DOSE- 3-4 G | Y | U | 0 | QD | |||||||
| 126733742 | 12673374 | 4 | SS | RIMIFON | ISONIAZID | 1 | Oral | Y | U | 0 | 300 | MG | QD | ||||||
| 126733742 | 12673374 | 5 | SS | ETHAMBUTOL HYDROCHLORIDE. | ETHAMBUTOL HYDROCHLORIDE | 1 | Oral | U | 0 | 1.5 | G | QD | |||||||
| 126733742 | 12673374 | 6 | SS | RHINADVIL | IBUPROFENPSEUDOEPHEDRINE HYDROCHLORIDE | 1 | Oral | Y | U | 0 | |||||||||
| 126733742 | 12673374 | 7 | C | INEXIUM | ESOMEPRAZOLE | 1 | 0 | 20 | MG | QD | |||||||||
| 126733742 | 12673374 | 8 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | 0 | 150 | UG | QD | |||||||||
| 126733742 | 12673374 | 9 | C | CACIT D3 | CALCIUMCHOLECALCIFEROL | 1 | 0 | ||||||||||||
| 126733742 | 12673374 | 10 | C | GAVISCON | ALUMINUM HYDROXIDEMAGNESIUM CARBONATE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126733742 | 12673374 | 1 | Tuberculosis |
| 126733742 | 12673374 | 2 | Tuberculosis |
| 126733742 | 12673374 | 4 | Tuberculosis |
| 126733742 | 12673374 | 5 | Tuberculosis |
| 126733742 | 12673374 | 6 | Nasopharyngitis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126733742 | 12673374 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126733742 | 12673374 | Alanine aminotransferase increased | |
| 126733742 | 12673374 | Aspartate aminotransferase increased | |
| 126733742 | 12673374 | Gamma-glutamyltransferase increased | |
| 126733742 | 12673374 | Hepatocellular injury | |
| 126733742 | 12673374 | Prothrombin time shortened |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126733742 | 12673374 | 1 | 20160625 | 20160720 | 0 | |
| 126733742 | 12673374 | 2 | 20160625 | 0 | ||
| 126733742 | 12673374 | 3 | 20160712 | 20160719 | 0 | |
| 126733742 | 12673374 | 4 | 20160625 | 20160720 | 0 | |
| 126733742 | 12673374 | 5 | 20160625 | 0 | ||
| 126733742 | 12673374 | 6 | 20160712 | 20160716 | 0 | |
| 126733742 | 12673374 | 8 | 201605 | 0 |